Showing results (1-10 of 275) with videos related to

Sort By:
Pageof 28
The Journal of Biological Chemistry|September 17, 2009
Evidence that integrin alpha IIb beta 3-dependent interaction of mast cells with fibrinogen exacerbates chronic inflammationToshihiko Oki, Koji Eto, Kumi Izawa, et al.
Journal of Cellular Physiology|March 5, 2009
Molecular bases of myelodysplastic syndromes: lessons from animal modelsYukiko Komeno, Jiro Kitaura, Toshio Kitamura
Gut|February 13, 2015
Ceramide-CD300f binding suppresses experimental colitis by inhibiting ATP-mediated mast cell activationToshihiro Matsukawa, Kumi Izawa, Masamichi Isobe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 30, 2009
An activating and inhibitory signal from an inhibitory receptor LMIR3/CLM-1: LMIR3 augments lipopolysaccharide response through association with FcRgamma in mast cellsKumi Izawa, Jiro Kitaura, Yoshinori Yamanishi, et al.
The Journal of Biological Chemistry|September 7, 2010
Characterization of leukocyte mono-immunoglobulin-like receptor 7 (LMIR7)/CLM-3 as an activating receptor: its similarities to and differences from LMIR4/CLM-5Yutaka Enomoto, Yoshinori Yamanishi, Kumi Izawa, et al.
The Journal of Biological Chemistry|January 12, 2017
Ceramide-CD300f Binding Inhibits Lipopolysaccharide-induced Skin InflammationEmiko Shiba, Kumi Izawa, Ayako Kaitani, et al.
Scientific Reports|February 7, 2014
A novel cell-cycle-indicator, mVenus-p27K-, identifies quiescent cells and visualizes G0-G1 transitionToshihiko Oki, Koutarou Nishimura, Jiro Kitaura, et al.
Scientific Reports|November 28, 2018
Mouse LIMR3/CD300f is a negative regulator of the antimicrobial activity of neutrophilsKeigo Ueno, Makoto Urai, Kumi Izawa, et al.
International Journal of Hematology|October 26, 2012
Upregulation of CD200R1 in lineage-negative leukemic cells is characteristic of AML1-ETO-positive leukemia in miceYuki Kagiyama, Jiro Kitaura, Katsuhiro Togami, et al.
The Journal of Biological Chemistry|April 18, 2007
Functional analysis of activating receptor LMIR4 as a counterpart of inhibitory receptor LMIR3Kumi Izawa, Jiro Kitaura, Yoshinori Yamanishi, et al.
Pageof 28